NODS: Intracellular proteins involved in inflammation and apoptosis

Nature Reviews Immunology

Volumn 3, Issue 5, 2003, Pages 371-382

  Inohara, Naohiro ^a   Nuñez, Gabriel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CRYOPYRIN; CYTOPLASM PROTEIN; MHC CLASS II TRANSACTIVATOR; NEURONAL APOPTOSIS INHIBITORY PROTEIN 5; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN 2; PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; CARD15 PROTEIN, HUMAN; CARD4 PROTEIN, HUMAN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL MODEL; APOPTOSIS; BLAU SYNDROME; COLD URTICARIA; CROHN DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVATION; GENETIC VARIABILITY; INFECTION SENSITIVITY; INFLAMMATION; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; HUMAN; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CARRIER PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, IMMUNOLOGICAL; MUTATION; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 0038624558     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1086     Document Type: Review

References (115)

1. Dangl, J. L. & Jones, J. D. Plant pathogens and integrated defence responses to infection. Nature 411, 826-833 (2001).
2. Medzhitov, R. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1, 135-145 (2001).
3. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2, 675-680 (2001).
4. Aballay, A. & Ausubel, F. M. Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl Acad. Sci. USA 98, 2735-2739 (2001).
5. Liu, Q. A. & Hengartner M. O. The molecular mechanism of programmed cell death in C. elegans. Ann. NY Acad. Sci. 887, 92-104 (1999).
6. Derry, W. B., Putzke, A. P. & Rothman, J. H. Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 294, 591-595 (2001).
7. Williams, B. R. PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112-6120 (1999).
8. Nanduri, S., Rahman, F., Williams, B. R. & Qin, J. A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J. 19, 5567-5574 (2000)
9. Philpott, D. J., Yamaoka, S., Israel, A. & Sansonetti, P. J. Invasive Shigella flexneri activates NF-κB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J. Immunol. 165, 903-914 (2000).
10. O'Riordan, M., Yi, C. H., Gonzales, R., Lee, K. D. & Portnoy, D. A. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl Acad. Sci. USA 99, 13861-13866 (2002).
11. Inohara, N. & Nuñez, G. The NOD: a signaling module that regulate apoptosis and host defense against pathogens. Oncogene 20, 6473-6481 (2001).
12. Inohara, N., Ogura, Y. & Nuñez, G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr. Opin. Microbiol. 5, 76-80 (2002).
13. Hull, K. M., Shoham, N., Chae, J. J., Aksentijevich, I. & Kastner, D. L. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr. Opin. Rheumatol. 15, 61-69 (2003).
14. van der Biezen, E. A. & Jones, J. D. The NB-ARC domain: a novel signalling motif shared by plant resistance gene products and regulators of cell death in animals. Curr. Biol. 8, R226-R227 (1998).
15. Hu, Y., Ding, L., Spencer, D. M. & Nuñez, G. WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation. J. Biol. Chem. 273, 33489-33494 (1998).
16. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T. & Alnemri, E. S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1, 949-957 (1998).
17. Yang, X., Chang, H. Y. & Baltimore, D. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science 281, 1355-1357 (1998).
18. Koonin, E. V. & Aravind, L. The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation. Trends Biochem. Sci. 25, 223-224 (2000).
19. The Arabidopsis Genome Initiative. Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408, 796-820 (2000).
20. Goff, S. A. et al. A draft sequence of the rice genome (Oryza sativa L. ssp. japonica). Science 296, 92-100 (2002).
21. Hofmann, K., Bucher, P. & Tschopp, J. The CARD domain: a new apoptotic signaling motif. Trends Biochem. Sci. 22, 155-156 (1997).
22. Bertin, J. & DiStefano, P. S. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 12, 1273-1274 (2000).
23. Martinon, F., Hofmann, K. & Tschopp, J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 11, R118-R120 (2001).
24. Staub, E., Dahl, E. & Rosenthal, A. The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem. Sci. 26, 83-85 (2001).
25. Pawlowski, K., Pio, F., Chu, Z., Reed, J. C. & Godzik, A. PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem. Sci. 26, 85-87 (2001).
26. Bertin, J. et al. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274, 12955-12958 (1999).
27. Inohara, N. et al. Nod1, an Apaf1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274, 14560-14567 (1999).
28. Ogura, Y. et al. Nod2, a Nod1/Apaf1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276, 4812-4818 (2001).
29. Manji, G. A. et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J. Biol. Chem. 277, 11570-11575 (2002).
30. Dowds, A. et al. Regulation of Cryopyrin/Pypaf1 signaling by pyrin, the familial mediterranean fever gene product. Biochem. Biophys. Res. Commun. 302, 575-580 (2003).
31. Harton, J. A. Linhoff, M. W., Zhang, J. & Ting, J. P. Cutting edge. CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nuclectide-binding, and leucine-rich repeat domains. J. Immunol. 169, 4088-4093 (2002).
32. Geddes, B. J. et al. Human CARD12 is a novel CED4/Apaf1 family member that induces apoptosis. Biochem. Biophys. Res. Commun. 284, 77-82 (2001).
33. Poyet, J. L. et al. Identification Of Ipaf, a human caspase-1- activating protein related to Apaf1. J. Biol. Chem. 276, 28309-28313 (2001).
34. Damiano, J. S. et al. Clan, a novel human Ced-4-like gene. Genomics 75, 77-83 (2001).
35. Hlaing, T. et al. Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J. Biol. Chem. 276, 9230-9238 (2001).
36. Chu, Z. L. et al. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 276, 9239-9245 (2001).
37. Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genet. 29, 301-305 (2001). The first evidence for a genetic association between cryopyrin and the development of familial cold urticaria and Muckle-Wells syndrome.
38. Wang, L. et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-κB and caspase-1-dependent cytokine processing. J. Biol. Chem. 277, 29874-29880 (2002).
39. Grenier, J. M. et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-κB and caspase-1. FEBS Lett. 530, 73-78 (2002).
40. Tong, Z. B., Bondy, C. A., Zhou, J. & Nelson, L. M. A human homologue of mouse mater, a maternal effect gene essential for early embryonic development. Hum. Reprod. 17, 903-911 (2002).
41. Roy, N. et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80, 167-178 (1995).
42. Xu, M. et al. Functional human NAIP promoter transcription regulatory elements for the NAIP and PsiNAIP genes. Biochim. Biophys. Acta 1574, 35-50 (2002).
43. Riedl, S. J. et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 104, 791-800 (2001).
44. Liu, Z. et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408, 1004-1008 (2000).
45. Wu, G. et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 408, 1008-1012 (2000).
46. Steimle, V., Otten, L. A., Zufferey, M. & Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146 (1993).
47. Reith, W. & Mach, B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19, 331-373 (2001).
48. Nickerson, K. et al. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity. J. Biol. Chem. 276, 19089-19093 (2001).
49. Lahaye, T. The Arabidopsis RRS1-R disease resistance gene - uncovering the plant's nucleus as the new battlefield of plant defense? Trends Plant Sci. 7, 425-427 (2002).
50. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426 (2002).
51. Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413 (1997). In this paper, the authors cloned and characterized APAF1, the first NOD protein to be identified in mammals.
52. Benedict, M. A., Hu, Y., Inohara, N & Nuñez, G. Expression and functional analysis of Apaf-1 isoforms. Extra WD-40 repeat is required for cytochrome-c binding and regulated activation of procaspase-9. J. Biol. Chem. 275, 8461-8468 (2000).
53. Qin, H. et al. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399, 549-557 (1999).
54. Saleh, A. et al. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. BioL Chem. 274, 17941-17945 (1999).
55. Inohara, N. et al. An induced proximity model for NF-κB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275, 27823-27831 (2000). This paper provides a general model for activation of NOD-LRR proteins through NOD oligomerization and induced proximity of downstream effectors.
56. Inohara, N. et al. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276, 2551-2554 (2001). The first evidence that NOD proteins recognize bacterial components.
57. Girardin, S. E. et al. CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2, 736-742 (2001).
58. Srinivasula, S. M. et al. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277, 21119-21122 (2002).
59. Masumoto, J. et al. ASC is an activating adaptor for NF-κB and caspase-8-dependent apoptosis. Biochem. Biophys. Res. Commun. 303, 69-73 (2003).
60. Kobayashi, K. et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-199 (2002).
61. Masumoto, J. et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274, 33835-33838 (1999).
62. Yoo, N. J. et al. Nod1, a CARD protein, enhances pro-interleukin-1β processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 299, 652-658 (2002).
63. Linhoff, M. W., Harton, J. A., Cressmann, D. E., Martin, B. K. & Ting, J. P. Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains. Mol. Cell. Biol. 21, 3001-3011 (2001).
64. Kretsovali, A., Spilianakis, C., Dimakopoulos, A., Makatounakis, T. & Papamatheakis, J. Self-association of class II transactivator correlates with its intracellular localization and transactivation. J. Biol. Chem. 276, 32191-32197 (2001).
65. Sisk, T. J., Roys, S. & Chang, C. H. Self-association of CIITA and its transactivation potential. Mol. Cell. Biol. 21, 4919-4928 (2001).
66. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001). This paper (together with reference 90) provides the first evidence that NOD2 mutations are associated with susceptibility to Crohn's disease. In addition, the paper provides the first evidence that disease variants are defective in the recognition of bacterial components.
67. Bonen, D. K. et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124, 140-146 (2003).
68. Inohara, N. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J. Biol. Chem 278, 5509-5512 (2003).
69. Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872 (2003).
70. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249-1255 (1999).
71. Matzinger P. The danger model: a renewed sense of self. Science 296, 301-305 (2002).
72. Aliprantis, A. O., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739 (1999).
73. Aliprantis, A. O., Yang, R. B., Weiss, D. S., Godowski, P. & Zychlinsky, A. The apoptotic signaling pathway activated by Toll-iike receptor-2. EMBO J. 19, 3325-3336 (2000).
74. Balachandran, S. et al. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17, 6888-6902 (1998).
75. Ashkenazi, A. & Dixit, V. M. Death receptors: signaling and modulation. Science 281, 1305-1308 (1998).
76. Beg, A. A. & Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784 (1996).
77. Wang, C. Y., Mayo, M, W., Korneluk, R. G., Goeddel, D. V. & Baldwin, A. S. Jr NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683 (1998).
78. Micheau, O., Lens, S., Gaide, O. Alevizopoulos, K. & Tschopp, J. NF-κB signals induce the expression of c-FLIP Mol. Cell. Biol. 21, 5299-5305 (2001).
79. Holtje, J. V. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol. Mol. Biol. Rev. 62, 181-203 (1998).
80. Nau, G. J. et al. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl Acad. Sci. USA 99, 1503-1508 (2002).
81. Takada, H. & Kotani, S. in The Theory and Practical Application of Adjuvants (ed. Stewart, D. E. S.) 171-202 (Wiley, Chichester, 1995).
82. Heinzelmann, M. et al. Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells. Immunopharmacology 48, 117-128 (2000).
83. Todate, A. et al. Muramyl dipeptide-Lys stimulates the function of human dendritic cells. J. Leukocyte Biol. 70, 723-739 (2001).
84. Gutierrez, O. et al. Induction of NOD2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J. Biol. Chem. 277, 41701-41705 (2002).
85. Yang, S. et al. Synergistic effect of muramyldipeptide with lipopolysaccharide of lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69, 2045-2053 (2001).
86. Ribi, E. E., Cantrell, J. L., Von Eschen, K. B. & Schwartzman, S. M. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Cancer Res. 39, 4756-4759 (1979).
87. Wolfert, M. A., Murray, T. F., Boons, G. J. & Moore, J. N. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277, 39179-39186 (2002).
88. Braun, L. & Cossart, P. Interactions between Listeria monocytogenes and host mammalian cells. Microbes Infect. 2, 803-811 (2000).
89. Wiszniewski, W. et al. Mutation in the class II transactivator leading to a mild immunodeficiency J. Immunol. 167, 1787-1794 (2001).
90. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411,599-603 (2001).
91. Hampe, J. et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925-1928 (2001).
92. Miceli-Richard, C. et al. CARD15 mutations in Blau syndrome. Nature Genet. 29, 19-20 (2001).
93. Wang, X. et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 46, 3041-3045 (2002).
94. Chamaillard, M. et al. Gene/environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl Acad. Sci. USA 100, 3455-3460 (2003).
95. Dode, C. et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am. J. Hum Genet. 70, 498-506 (2002).
96. Feldmann, J. et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 71, 198-203 (2002).
97. Aksentijevich, I. et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46, 3340-3348 (2002).
98. Aganna, E. et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 46, 2445-2452 (2002).
99. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial mediterranean fever. Cell 90, 797-807 (1997). The first evidence (together with reference 100) that pyrin mutations are associated with familial Mediterranean fever.
100. The French FMF Consortium. A candidate gene for familial mediterranean fever. Nature Genet. 17, 25-31 (1997).
101. Richards, N. et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 276, 39320-39329 (2001).
102. Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165 (1995).
103. Hsieh-Li, H. M. et al. A mouse model for spinal muscular atrophy. Nature Genet. 24, 66-70 (2000).
104. Yaraghi, Z., Korneluk, R. G. & MacKenzie, A. Cloning and characterization of the multiple murine homologues of NAIP (neuronal apoptosis inhibitory protein). Genomics 51, 107-113 (1998).
105. Diez, E. et al. Genetic and physical mapping of the mouse host resistance locus Lgn1. Mamm. Genome 8, 682-685 (1997).
106. Scharf, J. M. et al. The mouse Naip gene cluster on chromosome 13 encodes several distinct functional transcripts. Mamm. Genome 10, 1032-1035 (1999).
107. Beckers, M. C., Yoshida, S., Morgan, K., Skamene, E. & Gros, P. Natural resistance to infection with Legionella pneumophila: chromosomal localization of the Lgn1 susceptibility gene. Mamm. Genome 6, 540-545 (1995).
108. Dietrich, W. F., Damron, D. M., Isberg, R. R., Lander, E. S. & Swanson, M. S. Lgn1, a gene that determines susceptibility to Legionella pneumophila, maps to mouse chromosome 13. Genomics 26, 443-450 (1995).
109. Wright, E. K. et al. Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila. Curr. Biol. 13, 27-36 (2003).
110. Diez, E. et al. Birc 1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nature Genet. 33, 55-60 (2003).
111. Watarai, M. et al. Legionella pneumophila is internalized by a macropinocytotic uptake pathway controlled by the Dot/Icm system and the mouse Lgn1 locus. J. Exp. Med. 194, 1081-1096 (2001).
112. Eulgem, T., Rushton, P. J., Robatzek, S. & Somssich, I. E. The WRKY superfamily of plant transcription factors. Trends Plant Sci. 5, 199-206 (2000).
113. Fiorentino, L. et al. A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-α and interleukin-1β. J. Biol. Chem. 277, 35333-35340 (2002).
114. Diez, E., Yaraghi, Z., MacKenzie, A. & Gros, P. The neuronal apoptosis inhibitory protein (Naip) is expressed in macrophages and is modulated after phagocytosis and during intracellular infection with Legionella pneumophila. J. Immunol. 184, 1470-1477 (2000).
115. Tschopp, J., Martinon, F. & Burns, K. NALPs: a novel protein family involved in inflammation. Nature Rev. Mol. Cell. Biol. 4, 95-104 (2003).